Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Safety and Efficacy Study of Efgartigimod PH20 Subcutaneous in Adults with Primary Immune Thrombocytopenia
BulgariaStudy on the Effects of Ianalumab with Standard Therapy for Patients with Active Lupus Nephritis
CzechiaStudy on Low-Dose Aldesleukin and Ciclosporin for Patients with Newly Diagnosed Type 1 Diabetes Retaining Insulin Secretion
FranceStudy on Methotrexate and Phototherapy for Adults with Progressive Vitiligo
FranceStudy on the Safety and Tolerability of DNTH103 for Adults with Generalized Myasthenia Gravis
CzechiaStudy on the Effectiveness and Safety of Iptacopan for Patients with Primary IgA Nephropathy
BelgiumStudy on the Effectiveness of Ruxolitinib Cream for Adults with Moderate Atopic Dermatitis
BelgiumStudy on the Safety and Effectiveness of Upadacitinib and Prednisolone in Patients with Giant Cell Arteritis
BelgiumStudy on the Effectiveness and Safety of Reparixin for Adults with Acute Respiratory Distress Syndrome
GermanyStudy on the Effects of ARO-MUC5AC Inhalation Solution for Patients with Asthma and COPD
PolandStudy on the Effects and Safety of Guselkumab for Patients with Active Psoriatic Arthritis
BulgariaStudy on Long-Term Safety and Effectiveness of Liposomal Ciclosporin A for Patients with Bronchiolitis Obliterans Syndrome After Lung Transplantation
AustriaThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
